Platelet-rich vs. platelet-poor plasma injections as adjuvant therapy in carpal tunnel surgery .
Efficacy of platelet-rich plasma as an adjuvant to surgical carpal ligament release: a prospective, randomized controlled clinical trial.
Sci Rep. 2020 Feb 7;10(1):2085.Fifty patients with carpal tunnel syndrome unresponsive to conservative therapy and scheduled for a open carpal ligament release procedure were randomized to receive an injection of platelet-rich plasma or platelet-poor plasma into the incision site following the completion of surgery. The primary outcome of interest was hand grip strength in the affected hand. Secondary outcomes of interest included pain scores on the Wong-Baker Faces Scale (WBFS), the functional and symptoms sub-scores of the Boston Carpal Tunnel Symptom Questionnaire (BCTSQ), time to return to work and the Southampton Wound Assessment Scale (SWAS) for surgical wound healing. Follow up occurred 6 weeks post-operation. Results revealed no significant differences between the two groups in hand grip strength, time to return to work and SWAS scores. No significant improvements were observed in WBFS scores, BCTSQ function scores and BCTSQ symptom scores in either group.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics